Copyright
©The Author(s) 2019.
World J Clin Cases. Feb 26, 2019; 7(4): 405-418
Published online Feb 26, 2019. doi: 10.12998/wjcc.v7.i4.405
Published online Feb 26, 2019. doi: 10.12998/wjcc.v7.i4.405
Figure 1 Patient who experienced immune-mediated colitis 4 wk after ipilimumab therapy.
Colonoscopy showed a sigmoid colon with ulcers, diffuse erythema, and loss of vascularity.
- Citation: Som A, Mandaliya R, Alsaadi D, Farshidpour M, Charabaty A, Malhotra N, Mattar MC. Immune checkpoint inhibitor-induced colitis: A comprehensive review. World J Clin Cases 2019; 7(4): 405-418
- URL: https://www.wjgnet.com/2307-8960/full/v7/i4/405.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i4.405